MedTrace Logo

Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy

NCT00215761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 263

Last updated 2012-09-10

No results posted yet for this study

Summary

Comparison of AF-Burden in patients with paroxysmal atrial fibrillation and the necessity of a Dual-Chamber-Pacemaker-Therapy either with a DDD\[R\]60-Stimulation or AF prevention pacing. All Patients were stratified according to their existing drug therapy, e.g. Beta-Blocker or ACE-Inhibitor.

Conditions

Sponsors & Collaborators

  • Medtronic BRC

    collaborator INDUSTRY

  • Atrial Fibrillation Network

    lead OTHER

Principal Investigators

  • Andreas Schuchert, Prof. Dr. · University Cardiac Center, Hamburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-10-31
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00215761 on ClinicalTrials.gov